MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer

Abroad (travel likely)Recruiting

Conditions

Pancreatic Neoplasm · Pancreas Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Renji hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Yingbin Liu, PHD) · laoniulyb@163.com · 13918803900

Study leads

Yinbin Liu, PhD
Principal Investigator
RenJi Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive Methodology

Pancreatic Neoplasms

Abroad (travel likely)Recruiting

Montpellier, France

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Adjustment Disorder · Adjustment Disorder With Anxious Mood · Cancer

Abroad (travel likely)RecruitingPHASE2

Abbotsford, Australia · Northcote, Australia

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Pancreas Cancer · Metastatic Pancreatic Cancer · Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jacksonville, United States

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Cancer · Breast Cancer · Non-Small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China